Terms: = Germ cell tumor AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
126 results:
1.
Vaddi PK; Osborne DG; Nicklawsky A; Williams NK; Menon DR; Smith D; Mayer J; Reid A; Domenico J; Nguyen GH; Robinson WA; Ziman M; Gao D; Zhai Z; Fujita M
Front Immunol; 2023; 14():1173035. PubMed ID: 37197667
[TBL] [Abstract] [Full Text] [Related]
2.
Suzuki T; Takei J; Fukasawa N; Suzuki K; Ogawa D; Yamamoto Y; Akasaki Y; Murayama Y; Shimoda M; Miyake K; Tanaka T
World Neurosurg; 2023 Jul; 175():e1364-e1374. PubMed ID: 37187346
[TBL] [Abstract] [Full Text] [Related]
3. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments.
Liao P; Jiang M; Islam MS; Wang Y; Chen X
Front Immunol; 2023; 14():1097090. PubMed ID: 36865537
[TBL] [Abstract] [Full Text] [Related]
4. Upregulated Immunogenic cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas.
Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429083
[No Abstract] [Full Text] [Related]
5. Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study.
Shui IM; Liu XQ; Zhao Q; Kim ST; Sun Y; Yearley JH; Choudhury T; Webber AL; Krepler C; Cristescu R; Lee J
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793874
[TBL] [Abstract] [Full Text] [Related]
6. The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies.
Hosseinalizadeh H; Mahmoodpour M; Samadani AA; Roudkenar MH
Med Oncol; 2022 Jun; 39(9):130. PubMed ID: 35716323
[TBL] [Abstract] [Full Text] [Related]
7. Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.
Gartrell RD; Enzler T; Kim PS; Fullerton BT; Fazlollahi L; Chen AX; Minns HE; Perni S; Weisberg SP; Rizk EM; Wang S; Oh EJ; Guo XV; Chiuzan C; Manji GA; Bates SE; Chabot J; Schrope B; Kluger M; Emond J; Rabadán R; Farber D; Remotti HE; Horowitz DP; Saenger YM
Oncoimmunology; 2022; 11(1):2066767. PubMed ID: 35558160
[TBL] [Abstract] [Full Text] [Related]
8. Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment.
Star P; Jackett LA; Cheung K; Wilmott JS; Ho G; Smith A; Long GV; Scolyer RA; Martin LK
Dermatol Ther; 2022 Jun; 35(6):e15472. PubMed ID: 35347815
[TBL] [Abstract] [Full Text] [Related]
9. CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma.
Bozhanova G; Hassan J; Appleton L; Jennings V; Foo S; McLaughlin M; Chan Wah Hak CM; Patin EC; Crespo-Rodriguez E; Baker G; Armstrong E; Chiu M; Pandha H; Samson A; Roulstone V; Kyula J; Vile R; Errington-Mais F; Pedersen M; Harrington K; Ono M; Melcher A
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338089
[TBL] [Abstract] [Full Text] [Related]
10. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients.
Cuadrado-Vilanova M; Liu J; Paco S; Aschero R; Burgueño V; Sirab N; Pascual-Pasto G; Correa G; Balaguer-Lluna L; Castillo-Ecija H; Perez-Jaume S; Muñoz-Aznar O; Roldan M; Suñol M; Schaiquevich P; Aerts I; Doz F; Cassoux N; Lubieniecki F; Benitez-Ribas D; Lavarino C; Mora J; Chantada GL; Catala-Mora J; Radvanyi F; Carcaboso AM
J Pathol; 2022 Jul; 257(3):327-339. PubMed ID: 35254670
[TBL] [Abstract] [Full Text] [Related]
11. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract] [Full Text] [Related]
12. Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma.
Choi J; Medikonda R; Saleh L; Kim T; Pant A; Srivastava S; Kim YH; Jackson C; Tong L; Routkevitch D; Jackson C; Mathios D; Zhao T; Cho H; Brem H; Lim M
Oncoimmunology; 2021; 10(1):1956142. PubMed ID: 34484870
[TBL] [Abstract] [Full Text] [Related]
13. Retargeting IL-2 Signaling to NKG2D-Expressing tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.
Banerjee A; Li D; Guo Y; Mahgoub B; Paragas L; Slobin J; Mei Z; Manafi A; Hata A; Li K; Shi L; Westwick J; Slingluff C; Lazear E; Krupnick AS
J Immunol; 2021 Jul; 207(1):333-343. PubMed ID: 34155069
[TBL] [Abstract] [Full Text] [Related]
14. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH
Front Immunol; 2021; 12():654463. PubMed ID: 34054817
[TBL] [Abstract] [Full Text] [Related]
15. Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
Crotty EE; Smith SMC; Brasel K; Pakiam F; Girard EJ; Connor YD; Zindy F; Mhyre AJ; Roussel MF; Olson JM
J Neurooncol; 2021 Jun; 153(2):225-237. PubMed ID: 33963961
[TBL] [Abstract] [Full Text] [Related]
16. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract] [Full Text] [Related]
17. tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.
Somasundaram R; Connelly T; Choi R; Choi H; Samarkina A; Li L; Gregorio E; Chen Y; Thakur R; Abdel-Mohsen M; Beqiri M; Kiernan M; Perego M; Wang F; Xiao M; Brafford P; Yang X; Xu X; Secreto A; Danet-Desnoyers G; Traum D; Kaestner KH; Huang AC; Hristova D; Wang J; Fukunaga-Kalabis M; Krepler C; Ping-Chen F; Zhou X; Gutierrez A; Rebecca VW; Vonteddu P; Dotiwala F; Bala S; Majumdar S; Dweep H; Wickramasinghe J; Kossenkov AV; Reyes-Arbujas J; Santiago K; Nguyen T; Griss J; Keeney F; Hayden J; Gavin BJ; Weiner D; Montaner LJ; Liu Q; Peiffer L; Becker J; Burton EM; Davies MA; Tetzlaff MT; Muthumani K; Wargo JA; Gabrilovich D; Herlyn M
Nat Commun; 2021 Jan; 12(1):346. PubMed ID: 33436641
[TBL] [Abstract] [Full Text] [Related]
18. A novel foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG
Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364
[TBL] [Abstract] [Full Text] [Related]
19. C6 cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.
Singh D; Dromel PC; Perepelkina T; Baranov P; Young M
Cell Transplant; 2020; 29():963689720964383. PubMed ID: 33356508
[TBL] [Abstract] [Full Text] [Related]
20. Presence of tumor-infiltrating CD8
Johansson J; Siarov J; Kiffin R; Mölne J; Mattsson J; Naredi P; Olofsson Bagge R; Martner A; Lindnér P
Oncoimmunology; 2020 Dec; 9(1):1854519. PubMed ID: 33344043
[TBL] [Abstract] [Full Text] [Related]
[Next]